openPR Logo
Press release

Measles, Mumps and Rubella (MMR) Vaccines Market Enhancement in Medical Sector 2018 to 2026 And The Top Key Players Are GlaxoSmithKline (Belgium), Merck & Co. Inc. (USA) and Serum Institute of India

06-06-2019 09:40 AM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Measles, Mumps and Rubella (MMR) Vaccines

Measles, Mumps and Rubella (MMR) Vaccines

Measles, mumps, and rubella are the three common contagious airborne diseases that are highly caused by virus transmitted by sneezing and coughing of the infected person, which could lead to serious complications or death among children. Vaccines of these diseases are sold as attenuated viral vaccines, manufactured in a lyophilised formulation, which requires reconstitution with water for injection diluent and are available in two forms i.e. monovalent as well as combinational vaccines. Combinational MMR vaccines comprises mixture of two or more viral strains. These measles, mumps, and rubella vaccines are administered by subcutaneous injection to children as well as adults.

Download The PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1496

It is generally administered to children aged 1 year and second dosage can be administered as early as one month after the first dose. According to CDC, two doses of measles, mumps and rubella vaccine are 97% effective against measles and 88% effective against mumps. One dose of measles, mumps, and rubella vaccine is 93% effective against measles, 78% effective against mumps, and 97% effective against rubella.

Currently, few vaccines available in the measles, mumps, and rubella vaccine market are sold under the trade name of M-M-R II, ProQuad, and Attenuvax by Merck Co. Inc.; Varilrix, Priorixtetra and MMR by GSK; Trimovax by Sanofi Pasteur and Tresivac by Serum Institute of India.

Measles, Mumps, and Rubella Vaccine Market Drivers

Vaccine manufacturers are focusing on partnering with organizations such WHO, UNICEF, and GAVI Alliance to improve their vaccination programs, in order to reach the maximum population to offer vaccines. In spite of several governmental initiatives, measles is a leading cause of death among young children. Therefore, increasing success rate of vaccination programmes depends on government initiatives of each country.

Some organizations are focusing on initiative, in order to reduce the prevalence of these diseases. For instance, GAVI Alliances has undertaken an initiative to provide vaccination in high-risk countries such as Afghanistan, Chad, Ethiopia, the Democratic Republic of the Congo, Nigeria and Pakistan. Similarly, in 2017, the Government of India launches Pan-India Measles-Rubella vaccination campaign, under which children ages from 9 months to 15 years are vaccinated to reduce the incidence of these disease in children. Such initiatives by various organizations and governments is expected to aid in growth of the market.

Measles, Mumps, and Rubella Vaccine Market - Competitors

The major manufacturers with WHO prequalified measles, mumps, and rubella vaccines are GlaxoSmithKline (Belgium), Merck & Co. Inc. (USA) and Serum Institute of India Ltd, among others.

Request Cutsomization @ https://www.coherentmarketinsights.com/insight/request-customization/1496

The global measles, mumps, and rubella vaccines market is segment on the basis of geography into North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. According to the Pan American Health Organization (PAHO), 2017, measles and rubella have been eliminated from the Americas region, however, the challenge lies in preventing the outbreak. However, according to a report by CDC’s National Center for Immunization and Respiratory Diseases (NCIRD), in 2014, the U.S. recorded 667 number of measles cases from 27 states, which was the highest number of cases since measles elimination was documented in the U.S. in 2000. This states that the vaccine programs were unsuccessful in preventing the outbreak of the disease.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Measles, Mumps and Rubella (MMR) Vaccines Market Enhancement in Medical Sector 2018 to 2026 And The Top Key Players Are GlaxoSmithKline (Belgium), Merck & Co. Inc. (USA) and Serum Institute of India here

News-ID: 1766216 • Views: 785

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Measles

Measles Testing Market to be at Forefront by 2024
Global Measles Testing Market: Snapshot The global measles testing market is anticipated to showcase a record growth during the forecast period 2016–2024. This could be on account of the recent developments in the field of automation and most importantly, immunodiagnostic technology. There is an elevating awareness about measles across the globe and its outbreak especially in the developing countries of the world. New companies entering the market with novel ways of
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Global Measles Market Report 2019 By Valuates Reports
Global Measles Market Report 2019 - Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Measles industry. Measles is a highly contagious infectious disease caused by the measles virus. Symptoms usually develop 10–12 days after exposure to an infected person and last 7–10 days. Initial symptoms typically include fever, often greater than 40 °C (104 °F), cough, runny nose,
Measles Vaccine Market 2019-2025: Expansive implementation enhance growth
Measles Vaccine Market research report examines adoption trends, future growth potentials, key drivers, competitive outlook, restraints, opportunities, key challenges, Measles Vaccine industry ecosystem, and revenue chain analysis. This report presents a detailed analysis, market sizing, and forecasting up to 6 Year 2019-2025 for the emerging segment within the Measles Vaccine market. The report is thoroughly segmented by product type, application, vertical, and region. The points that are discussed within the
Measles Testing Market Size to Expand Significantly by 2024
Being one of the most common causes of death among kids, measles has become a global problem despite the fact that there are cost-effective and safe vaccines available for its prevention. This highly contagious disease killed an estimated 134,200 people in 2015, according to findings of the World Health Organization (WHO), which amounts to nearly 15 deaths on an hourly basis. However, growing awareness among the general population regarding vaccination and
Measles Therapeutic Clinical Trials Market Review, H2 2018
Summary “Measles Global Clinical Trials Review, H2, 2017" provides an overview of Measles clinical trials scenario. This report provides top line data relating to the clinical trials on Measles. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report